Zhao P - Search Results

1

ARID1A Hypermethylation Disrupts Transcriptional Homeostasis to Promote Squamous Cell Carcinoma Progression.

Luo Q, Wu X, Chang W, Zhao P, Zhu X, Chen H, Nan Y, Luo A, Zhou X, Su D, Jiao W, Liu Z. Luo Q, et al. Among authors: zhao p. Cancer Res. 2020 Feb 1;80(3):406-417. doi: 10.1158/0008-5472.CAN-18-2446. Cancer Res. 2020. PMID: 32015157

2

ARID1A ablation leads to multiple drug resistance in ovarian cancer via transcriptional activation of MRP2.

Luo Q, Wu X, Zhang Y, Shu T, Ding F, Chen H, Zhao P, Chang W, Zhu X, Liu Z. Luo Q, et al. Among authors: zhao p. Cancer Lett. 2018 Jul 28;427:9-17. doi: 10.1016/j.canlet.2018.04.013. Epub 2018 Apr 13. Cancer Lett. 2018. PMID: 29660381

3

MGMT-activated DUB3 stabilizes MCL1 and drives chemoresistance in ovarian cancer.

Wu X, Luo Q, Zhao P, Chang W, Wang Y, Shu T, Ding F, Li B, Liu Z. Wu X, et al. Among authors: zhao p. Proc Natl Acad Sci U S A. 2019 Feb 19;116(8):2961-2966. doi: 10.1073/pnas.1814742116. Epub 2019 Feb 4. Proc Natl Acad Sci U S A. 2019. PMID: 30718431 Free PMC article.

4

JOSD1 inhibits mitochondrial apoptotic signalling to drive acquired chemoresistance in gynaecological cancer by stabilizing MCL1.

Wu X, Luo Q, Zhao P, Chang W, Wang Y, Shu T, Ding F, Li B, Liu Z. Wu X, et al. Among authors: zhao p. Cell Death Differ. 2020 Jan;27(1):55-70. doi: 10.1038/s41418-019-0339-0. Epub 2019 May 1. Cell Death Differ. 2020. PMID: 31043700 Free PMC article.

5

ARID1A prevents squamous cell carcinoma initiation and chemoresistance by antagonizing pRb/E2F1/c-Myc-mediated cancer stemness.

Luo Q, Wu X, Chang W, Zhao P, Nan Y, Zhu X, Katz JP, Su D, Liu Z. Luo Q, et al. Among authors: zhao p. Cell Death Differ. 2020 Jun;27(6):1981-1997. doi: 10.1038/s41418-019-0475-6. Epub 2019 Dec 12. Cell Death Differ. 2020. PMID: 31831874 Free PMC article.

6

TRIM32/USP11 Balances ARID1A Stability and the Oncogenic/Tumor-Suppressive Status of Squamous Cell Carcinoma.

Luo Q, Wu X, Nan Y, Chang W, Zhao P, Zhang Y, Su D, Liu Z. Luo Q, et al. Among authors: zhao p. Cell Rep. 2020 Jan 7;30(1):98-111.e5. doi: 10.1016/j.celrep.2019.12.017. Cell Rep. 2020. PMID: 31914402 Free article.

7

Correction: ARID1A Hypermethylation Disrupts Transcriptional Homeostasis to Promote Squamous Cell Carcinoma Progression.

Luo Q, Wu X, Chang W, Zhao P, Zhu X, Chen H, Nan Y, Luo A, Zhou X, Su D, Jiao W, Liu Z. Luo Q, et al. Among authors: zhao p. Cancer Res. 2020 Oct 1;80(19):4302. doi: 10.1158/0008-5472.CAN-20-2613. Cancer Res. 2020. PMID: 33008806 No abstract available.

8

Corrigendum to 'ARID1A ablation leads to multiple drug resistance in ovarian cancer via transcriptional activation of MRP2' [Canc. Lett. 427 (2018) 9-17].

Luo Q, Wu X, Zhang Y, Shu T, Ding F, Chen H, Zhao P, Chang W, Zhu X, Liu Z. Luo Q, et al. Among authors: zhao p. Cancer Lett. 2021 Feb 1;498:243. doi: 10.1016/j.canlet.2020.10.027. Epub 2020 Oct 22. Cancer Lett. 2021. PMID: 33342532 No abstract available.

9

OTUD1 Activates Caspase-Independent and Caspase-Dependent Apoptosis by Promoting AIF Nuclear Translocation and MCL1 Degradation.

Luo Q, Wu X, Zhao P, Nan Y, Chang W, Zhu X, Su D, Liu Z. Luo Q, et al. Among authors: zhao p. Adv Sci (Weinh). 2021 Feb 8;8(8):2002874. doi: 10.1002/advs.202002874. eCollection 2021 Apr. Adv Sci (Weinh). 2021. PMID: 33898171 Free PMC article.

10

DLGAP1-AS2-Mediated Phosphatidic Acid Synthesis Activates YAP Signaling and Confers Chemoresistance in Squamous Cell Carcinoma.

Nan Y, Luo Q, Wu X, Liu S, Zhao P, Chang W, Zhou A, Liu Z. Nan Y, et al. Among authors: zhao p. Cancer Res. 2022 Aug 16;82(16):2887-2903. doi: 10.1158/0008-5472.CAN-22-0717. Cancer Res. 2022. PMID: 35731019

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,739 results

Search Page

Filters